Please provide your email address to receive an email when new articles are posted on . Human growth hormone therapy was associated with increased risk for proximal tibial physeal avulsion fractures.
In a bid to protect sales for its human growth hormone drug Genotropin, Pfizer licensed rights to a longer-lasting human growth hormone therapy, hGH-CTP, in December. This longer-lasting drug has just ...
The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for children ...
Imagine a component in your body that assists you in transforming from a child into a mature person, helps your body heal itself when you get injured, and also keeps you healthy as you get older. One ...
Please provide your email address to receive an email when new articles are posted on . In a phase 3 trial, lonapegsomatropin was associated with more fat loss in the trunk than placebo. Body ...
Global Human Growth Hormone (HGH) Market · GlobeNewswire Inc. Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "Human Growth Hormone (HGH) Market Report by Application, Distribution Channel, Route of ...
Five patients in the United Kingdom have developed Alzheimer’s disease that appears to be the result of contaminated injections they received as children decades ago, according to a new study that ...
Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "Human Growth Hormone (HGH) Market Report by Application, Distribution Channel, Route of Administration and Company Analysis, 2025-2033" has been added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results